3164.TW · GENMONT
Taiwan · RS rating 60 · As of 2026-10-08
| Price | 16.95 TWD |
|---|---|
| 1-day change | +1.5% |
| RS rating (overall / 1M / 3M / 12M) | 60 / 75 / 71 / 38 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 32 / 28 / 40 |
| Industry group (rank) | Biotechnology & Medical Care (50) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +15.9% |
| Distance from 52-week high | +12.2% |
| Market cap (USD) | $44.4M |